Lipid Disorders
News
FDA approves alogliptin, alone and in combinations
News
HDL-raising: A good hypothesis gone bad
News
Metabolic syndrome skews Oncotype DX reliability
Major Finding: Of 322 patients with low-risk early-stage breast cancer, 89 (27%) met World Health Organization criteria for metabolic syndrome. So...
Conference Coverage
How to prevent 1 million coronary events
Major Finding: If all of the nation’s type 2 diabetic adults were to reach guideline-recommended goals for blood pressure, HbA1c, HDL, and total...
News
FDA panel backs approval of canagliflozin for type 2 diabetes
News
SSRIs for PTSD bring cardiometabolic benefits
Major Finding: The relative risk of metabolic syndrome in middle-aged veterans with PTSD was 71% lower with SSRI therapy than without it.
News
Bariatric surgery cut vascular events in diabetes
Major Finding: Bariatric surgery was linked to a 64% decrease in macro- and microvascular events compared with no surgery in obese type 2 diabetes...
News
Fatty Liver Disease: The Silent Epidemic
Conference Coverage
Statins' Diabetogenic Impact Influenced by Underlying Risks
Major Finding: High-dose atorvastatin raised the relative risk for incident diabetes 24% in patients with two or more diabetes risk factors.Data...
News
PCSK9 Antibodies Safely Cut LDL in Phase II
Major Finding: Patients on the largest Amgen 145 dosage had an average 66% reduction in their LDL cholesterol, and 90% reached their goal LDL...